| Assay ID | Title | Year | Journal | Article |
|---|
| AID1810061 | Antibiofilm activity against Staphylococcus epidermidis ATCC14990 assessed as inhibition of CV-staining/biomass formation measured after overnight incubation by biofilm inhibition assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1575544 | Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 assessed as as reduction in bacterial load by measuring reduction in colony forming units at 50 uM preincubated for 1 min followed by subculturing and further incubate | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1722941 | Antibacterial activity against Klebsiella pneumoniae ATTC 13883 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1810060 | Antibiofilm activity against methicillin-resistant Staphylococcus aureus SAP 0017 assessed as inhibition of CV-staining/biomass formation measured after overnight incubation by biofilm inhibition assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID551748 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1722949 | Antibiofilm activity against Klebsiella pneumoniae ATTC 13883 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1810063 | Antibiofilm activity against methicillin-resistant Staphylococcus aureus USA300 LAC assessed as minimal biofilm eradication concentration required for complete inhibition of bacterial growth by Calgary biofilm device assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1575565 | Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 at 50 uM after 5 to 10 mins by time-kill kinetic assay relative to control | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1575554 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 at 50 uM treated with 18 days old solution of test compound for 10 mins relative to control | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1722946 | Antibiofilm activity against Escherichia coli ATTC 489 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1722940 | Antibacterial activity against Acinetobacter baumannii 17918 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID551746 | Antibacterial activity against Staphylococcus aureus ATCC 25923 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1810065 | Antibiofilm activity against Staphylococcus epidermidis ATCC14990 assessed as biofilm eradication concentration by Calgary biofilm device assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1722937 | Antibacterial activity against Pseudomonas aeruginosa PAO1 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1575555 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 assessed as as reduction in bacterial load by measuring reduction in colony forming units at 50 uM treated with 111 days old solution of test compound for 10 mins fol | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID551751 | Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1810064 | Antibiofilm activity against methicillin-resistant Staphylococcus aureus SAP 0017 assessed as biofilm eradication concentration by Calgary biofilm device assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID551744 | Antibacterial activity against Mycobacterium smegmatis ATCC 14468 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID551749 | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1722943 | Antibiofilm activity against methicillin-resistant Staphylococcus aureus USA300 LAC incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1575556 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 at 50 uM treated with 111 days old solution of test compound for 10 mins relative to control | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1722942 | Antibiofilm activity against methicillin-resistant Staphylococcus aureus SAP0017 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1810057 | Antimicrobial activity against Staphylococcus epidermidis ATCC14990 assessed as inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1575545 | Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 assessed as as reduction in bacterial load by measuring reduction in colony forming units at 50 uM preincubated for 3 min followed by subculturing and further incubate | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1722944 | Antibiofilm activity against Pseudomonas aeruginosa PA14 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1575571 | Cytotoxicity against human HEK293 cells assessed as reduction in viability at 25 uM after 48 hrs by MTT assay relative to control | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID551745 | Antibacterial activity against Escherichia coli ATCC 25922 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID551747 | Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1722947 | Antibiofilm activity against Acinetobacter baumannii 5015 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1722936 | Antibacterial activity against Pseudomonas aeruginosa PA14 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1722945 | Antibiofilm activity against Pseudomonas aeruginosa PAO1 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1722935 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 LAC measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1150899 | Critical micelle concentration of the compound | 1976 | Journal of medicinal chemistry, Jun, Volume: 19, Issue:6
| Effect of chain length on critical micelle formation and protein binding of quaternary ammonium compounds. |
| AID1722939 | Antibacterial activity against Acinetobacter baumannii 5015 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1810055 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus USA300 LAC assessed as inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1722938 | Antibacterial activity against Escherichia coli ATTC 489 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1810066 | Antibiofilm activity against Enterococcus faecium assessed as biofilm eradication concentration by Calgary biofilm device assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1575557 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 assessed as as reduction in bacterial load by measuring reduction in colony forming units at 50 uM treated with 18 days old solution of test compound for 10 mins foll | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1575537 | Cytotoxicity against human HEK293 cells after 48 hrs by MTT assay | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1810062 | Antibiofilm activity against Enterococcus faecium assessed as inhibition of CV-staining/biomass formation measured after overnight incubation by biofilm inhibition assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1150900 | Binding affinity to bovine serum albumin after overnight incubation by equilibrium dialysis | 1976 | Journal of medicinal chemistry, Jun, Volume: 19, Issue:6
| Effect of chain length on critical micelle formation and protein binding of quaternary ammonium compounds. |
| AID1575563 | Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 at 50 uM after 1 min by time-kill kinetic assay relative to control | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1722948 | Antibiofilm activity against Acinetobacter baumannii 17918 incubated for 24 hrs under shaking condition by turbidometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1575564 | Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 at 50 uM after 3 mins by time-kill kinetic assay relative to control | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1810058 | Antimicrobial activity against Enterococcus faecium assessed as inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID551750 | Antibacterial activity against Enterococcus faecalis ATCC 29212 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1810056 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus SAP 0017 assessed as inhibition of bacterial growth incubated for 18 to 20 hrs by broth microdilution assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1722934 | Antibacterial activity against methicillin-resistant Staphylococcus aureus SAP0017 measured after overnight incubation by microtitre plate based spectrophotometric method | 2020 | Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
| Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo Activity. |
| AID1810059 | Antibiofilm activity against methicillin-resistant Staphylococcus aureus USA300 LAC assessed as inhibition of CV-staining/biomass formation measured after overnight incubation by biofilm inhibition assay | 2021 | Journal of medicinal chemistry, 11-25, Volume: 64, Issue:22
| Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response. |
| AID1575546 | Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC BAA 1707 assessed as as reduction in bacterial load by measuring reduction in colony forming units at 50 uM preincubated for 5 to 10 min followed by subculturing and further in | 2019 | MedChemComm, May-01, Volume: 10, Issue:5
| Rapid kill assessment of an |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347424 | RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347407 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347425 | Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |